Insider · CIK 0001767644
Todd R. Brady
Files at CTNM (Contineum Therapeutics, Inc.). First filing -, latest -.
Todd R. Brady files SEC Form 4 as director at CTNM (Contineum Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Todd R. Brady has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | CTNM Contineum Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +19,000 | $0.00 | $0 | 19,000 | Jun 26, 2026 |
| Jun 26, 2025 | CTNM Contineum Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +14,750 | $0.00 | $0 | 14,750 | Jun 26, 2025 |
Questions about Todd R. Brady
Answered from the filings on this page, as of the latest one.
Is Todd R. Brady buying or selling?
Todd R. Brady has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Todd R. Brady's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Todd R. Brady has 0.
Where does Todd R. Brady file Form 4?
Todd R. Brady has filed Form 4 at CTNM (Contineum Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.